We investigated the effect of cytochalasin D on anaphylaxis. Cytochala
sin D dose-dependently inhibited systemic anaphylaxis induced by compo
und 48/80 in rats. Especially, cytochalasin D inhibited compound 48/80
-induced systemic anaphylaxis 100% with a dose of 1 mu g g(-1) body we
ight (BW). Cytochalasin D significantly inhibited serum histamine leve
ls induced by compound 48/80. Cytochalasin D (10(-1) mu g g(-1) BW) al
so inhibited local anaphylaxis activated by anti-dinitrophenyl (DNP) I
gE to 79.6 +/- 1.8%. Cytochalasin D dose-dependently inhibited histami
ne release from the rat peritoneal mast cells activated by compound 48
/80 or anti-DNP IgE. The level of cAMP in rat peritoneal mast cells, w
hen cytochalasin D was added, transiently and significantly increased
about fourfold compared with that of basal cells. Our studies provide
evidence that cytochalasin D will be beneficial in the treatment of an
aphylaxis. (C) 1997 The Italian Pharmacological Society.